DK0537166T3 - Vandopløselige polypeptider med stor affinitet for alfa og beta-interferon - Google Patents

Vandopløselige polypeptider med stor affinitet for alfa og beta-interferon

Info

Publication number
DK0537166T3
DK0537166T3 DK91909065T DK91909065T DK0537166T3 DK 0537166 T3 DK0537166 T3 DK 0537166T3 DK 91909065 T DK91909065 T DK 91909065T DK 91909065 T DK91909065 T DK 91909065T DK 0537166 T3 DK0537166 T3 DK 0537166T3
Authority
DK
Denmark
Prior art keywords
water
high affinity
alpha
soluble polypeptides
beta interferon
Prior art date
Application number
DK91909065T
Other languages
English (en)
Inventor
Pierre Eid
Ion Gresser
Georges Lutfalla
Fran Ois Meyer
Knud Erik Mogensen
Michael Tovey
Gilles Uze
Erik Mogensen Knud
Original Assignee
Medisup Int Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25675747&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0537166(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Medisup Int Nv filed Critical Medisup Int Nv
Application granted granted Critical
Publication of DK0537166T3 publication Critical patent/DK0537166T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK91909065T 1991-04-17 1991-04-17 Vandopløselige polypeptider med stor affinitet for alfa og beta-interferon DK0537166T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/FR1991/000318 WO1992018626A1 (fr) 1991-04-17 1991-04-17 POLYPEPTIDES HYDROSOLUBLES AYANT UNE HAUTE AFFINITE POUR LES INTERFERONS α ET $g(b)
CA002085469A CA2085469C (fr) 1991-04-17 1991-04-17 Polypeptides hydrosolubles ayant une haute affinite pour les interferons .alpha. et .beta.

Publications (1)

Publication Number Publication Date
DK0537166T3 true DK0537166T3 (da) 1999-11-22

Family

ID=25675747

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91909065T DK0537166T3 (da) 1991-04-17 1991-04-17 Vandopløselige polypeptider med stor affinitet for alfa og beta-interferon

Country Status (12)

Country Link
US (1) US6475983B1 (da)
EP (1) EP0537166B1 (da)
JP (1) JPH05507614A (da)
KR (1) KR0172969B1 (da)
AT (1) ATE181961T1 (da)
AU (1) AU653937B2 (da)
CA (2) CA2085469C (da)
DE (1) DE69131426T2 (da)
DK (1) DK0537166T3 (da)
ES (1) ES2133285T3 (da)
GR (1) GR3031369T3 (da)
WO (1) WO1992018626A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0563487A1 (en) * 1992-03-31 1993-10-06 Laboratoire Europeen De Biotechnologie S.A. Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon
US5821078A (en) * 1992-09-03 1998-10-13 Yeda Research And Development Co. Ltd. Nucleic acid encoding interferon-α/β binding protein
IL108584A (en) * 1994-02-07 2008-03-20 Yeda Res & Dev Cloning of the interferon-binding protein ALPHA / BETA
IL107378A (en) * 1993-10-24 2005-05-17 Yeda Res & Dev SOLUBLE INTERFERON alpha-RECEPTOR, ITS PREPARATION AND USE
AU4411699A (en) * 1998-06-05 1999-12-20 Human Genome Sciences, Inc. Interferon receptor hkaef92
AU3725600A (en) * 1999-03-02 2000-09-21 Maxygen, Inc. Surrogate orphan ligands for orphan receptors
MXPA03006100A (es) * 2001-01-09 2005-02-14 Baylor Reserch Inst Metodos para tratar enfermedades auto inmunes en un sujeto y examenes de diagnostico en tubo de ensayo.
US20050176108A1 (en) * 2003-03-13 2005-08-11 Young-Min Kim Physiologically active polypeptide conjugate having prolonged in vivo half-life
US20040180054A1 (en) * 2003-03-13 2004-09-16 Hanmi Pharm. Co., Ltd. Physiologically active polypeptide conjugate having prolonged in vivo half-life
KR100725315B1 (ko) * 2003-11-13 2007-06-07 한미약품 주식회사 면역글로불린 단편을 이용한 단백질 결합체 및 그의제조방법
SI1711207T1 (sl) 2003-12-10 2013-07-31 Medarex, L.L.C Protitelesa interferona alfa in njihova raba
US7888481B2 (en) * 2005-02-10 2011-02-15 Baylor Research Institute Anti-interferon alpha monoclonal antibodies and methods for use
BRPI0607490A2 (pt) 2005-02-10 2009-09-08 Baylor Res Inst anticorpos monoclonais antiinterferon alfa e métodos para uso
US7732167B2 (en) * 2005-06-17 2010-06-08 Regeneron Pharmaceuticals, Inc. Interferon-α/β binding fusion proteins and therapeutic uses thereof
RU2532832C2 (ru) 2008-05-07 2014-11-10 Аргос Терапьютикс, Инк. Гуманизированные антитела против альфа-интерферона человека
SG11202001311VA (en) * 2017-08-22 2020-03-30 Sanabio Llc Soluble interferon receptors and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516515A (en) * 1986-02-05 1996-05-14 Interferon Sciences, Inc. Separation of alpha interferon receptor proteins and antibodies therefor
US5216128A (en) * 1989-06-01 1993-06-01 Yeda Research And Development Co., Ltd. IFN-β2/IL-6 receptor its preparation and pharmaceutical compositions containing it
US5395760A (en) * 1989-09-05 1995-03-07 Immunex Corporation DNA encoding tumor necrosis factor-α and -β receptors
IL91562A0 (en) * 1989-09-07 1990-04-29 Yeda Res & Dev Interferon-gamma receptor fragment and its production
US5889151A (en) * 1989-10-20 1999-03-30 Societe Leb-Tech Purified human alpha interferon receptor
FR2657881A1 (fr) * 1990-02-05 1991-08-09 Europ Biotechnologie Lab Nouveaux polypeptides hydrosolubles, sequences d'adn, nouvelles cellules, procede de preparation, applications et compositions renfermant lesdits polypeptides.
US5218090A (en) * 1990-06-12 1993-06-08 Warner-Lambert Company EGF receptor truncates
IL107378A (en) * 1993-10-24 2005-05-17 Yeda Res & Dev SOLUBLE INTERFERON alpha-RECEPTOR, ITS PREPARATION AND USE

Also Published As

Publication number Publication date
CA2585487A1 (fr) 1992-10-29
AU653937B2 (en) 1994-10-20
US6475983B1 (en) 2002-11-05
KR0172969B1 (ko) 1999-02-01
GR3031369T3 (en) 2000-01-31
ATE181961T1 (de) 1999-07-15
AU7792791A (en) 1992-11-17
DE69131426T2 (de) 2000-01-27
EP0537166B1 (fr) 1999-07-07
DE69131426D1 (de) 1999-08-12
JPH05507614A (ja) 1993-11-04
ES2133285T3 (es) 1999-09-16
WO1992018626A1 (fr) 1992-10-29
CA2085469C (fr) 2007-07-31
CA2085469A1 (fr) 1992-10-18
EP0537166A1 (fr) 1993-04-21

Similar Documents

Publication Publication Date Title
DK0537166T3 (da) Vandopløselige polypeptider med stor affinitet for alfa og beta-interferon
EE200100223A (et) Interferoon-beetaga sulandatud valgud ja nende kasutamine
ES2156852T3 (es) Citoquina mamifera, il-11.
ES8103976A1 (es) Un metodo de producir proteinas de interferon humano de for-ma le
FI90983C (fi) Menetelmä yhdistelmäinterferonipolypeptidien valmistamiseksi
NZ242857A (en) Heregulin polypeptide compositions, sequences, antibodies, purification, amplification and diagnostic tests
NO860362L (no) Keramiske komposittgjenstander og fremgangsmaater for fremstilling derav.
GR80840B (en) Novel polypeptide with a - amylase inhibiting effect, method for the preparation thereof, use and pharmaceutical preparations thereof
ES2009215A6 (es) Procedimiento de preparar un derivado de interleucina-1beta.
DE3486111T2 (de) Menschliches gamma-Interferonpolypeptidderivat.
DE3773295D1 (de) Homogene rekombinante immun-interferon-fragmente und diese enthaltende pharmazeutische zusammensetzungen.
DK502988D0 (da) Polypeptider med interferon- eller interferon-gamma-lignende aktivitet, fremgangsmaade til fremstilling deraf, vektorer, der koder disse polypeptider og farmaceutiske praeparater indeholdende saadanne
IL92685A0 (en) Dna encoding lymphokine/cytokine like proteins,cells transformed thereby and production of said proteins and antibodies against them
IL106591A0 (en) An interferon alpha/beta binding protein,its preparation and pharmaceutical compositions containing it
EE9400337A (et) Alfainterferooni sisaldavad farmatseutilised kompositsioonid ja nende kasutusvõimalused
ZA877354B (en) New monoclonal antibodies against ifn-omega,processes for preparing them and their use in the purification and detection of ifn-omega
IL86710A0 (en) Polypeptide receptor for interleukin-2,antibodies against this polypeptide and pharmaceutical compositions containing the same
DE68918399D1 (de) Lymphokine, DNS-Sequenzen, die diese Lymphokine kodieren, und sie enthaltende pharmazeutische Zusammensetzungen.
ATE342972T1 (de) Ifn rezeptor 1 bindende proteine, dafür kodierende dna und verfahren zur regulierung der zellulären antwort auf interferone
ATE75488T1 (de) Analoge interferon-polypeptide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DK0427633T3 (da) Anvendelse af et polypeptid med gammainterferonaktivitet til fremstilling af farmaceutiske præparater beregnet til behandling af primitiv pleuracancer
RU92016519A (ru) Полипептид, днк, клетка, способ получения полипептида, лекарственное средство, фармацевтическая композиция, применение полипептида
ATE87334T1 (de) Menschliches gamma-interferonpolypeptidderivat.
IT1199965B (it) Peptide,procedimento microbiologico per la sua produzione e suo impiego come agente antibiotico,citotossico e fitotossico